Drug
K-877 clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How studies write it
Studies that test it under each name
Name
Studies by the year they started
5 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Tofogliflozin (2) · Peptidoglycan Complex of Spirulina K-001 (1) · Moxifloxacin (1)
Studies
Open first, then newest update. How each study uses K-877 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver FibrosisCompletedPhase 2Kowa Research Institute, Inc.NCT05327127Written as K-877-ER
- Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IRCompletedPhase 2Kowa Research Institute, Inc.NCT04447820Written as K-877-ER (Dose A)
- Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452CompletedPhase 1Kowa Research Institute, Inc.NCT05722262Written as K-877-ER
- Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.CompletedPhase 1Kowa Research Institute, Inc.NCT03702673Written as K-877 CR Tablet A
- A Thorough Corrected QT Interval TrialCompletedPhase 1Kowa Research Institute, Inc.NCT02073084Written as K-877 Low Dose